CCR12P

Across TCGA pan-cancer cohorts, CCR12P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated CCR12P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher CCR12P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CCR12P expression acts as an unfavorable survival marker, although some lineages such as HNSC and CHOL show a favorable association.

HNSC, COAD, and ACC are the cancer types where CCR12P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.450	0.283	.001	144	view →
COAD	DFS	Tertile	III,IV	0.406	0.727	.007	81	view →
ACC	OS	Tertile	All	0.133	0.686	.004	36	view →
THCA	OS	Tertile	IV	0.841	1.000	.002	27	view →
LUAD	DFS	Quartile	IV	0.416	0.749	.023	18	view →
DLBC	DFS	Quartile	III,IV	0.074	1.000	.017	16	view →
CHOL	DFS	Tertile	All	0.830	0.228	.026	15	view →
ESCA	DFS	Median	III,IV	0.474	0.228	.008	12	view →
PAAD	DFS	Tertile	III,IV	0.152	0.821	.045	9	view →
THYM	OS	Median	All	0.956	0.585	.006	6	view →
LUSC	DFS	Quartile	III,IV	0.173	0.643	.031	4	view →
KIRP	OS	Tertile	All	0.323	0.725	.026	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

CCR12P–HNSC (DFS)

Open the HNSC breakdown →